title: Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.
authors.affiliation: Huntsman Cancer Institute at University of Utah, Salt Lake City.
authors.forename: N Jewel
authors.initials: NJ
authors.lastname: Samadder
authors.affiliation: Huntsman Cancer Institute at University of Utah, Salt Lake City.
authors.forename: Deborah W
authors.initials: DW
authors.lastname: Neklason
authors.affiliation: Huntsman Cancer Institute at University of Utah, Salt Lake City.
authors.forename: Randall W
authors.initials: RW
authors.lastname: Burt
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004379:Duodenal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000970:Antineoplastic Agents